1gag: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
New page: left|200px<br /> <applet load="1gag" size="450" color="white" frame="true" align="right" spinBox="true" caption="1gag, resolution 2.7Å" /> '''CRYSTAL STRUCTURE OF...
 
OCA (talk | contribs)
No edit summary
Line 1: Line 1:
[[Image:1gag.gif|left|200px]]<br />
[[Image:1gag.gif|left|200px]]<br /><applet load="1gag" size="350" color="white" frame="true" align="right" spinBox="true"  
<applet load="1gag" size="450" color="white" frame="true" align="right" spinBox="true"  
caption="1gag, resolution 2.7&Aring;" />
caption="1gag, resolution 2.7&Aring;" />
'''CRYSTAL STRUCTURE OF THE INSULIN RECEPTOR KINASE IN COMPLEX WITH A BISUBSTRATE INHIBITOR'''<br />
'''CRYSTAL STRUCTURE OF THE INSULIN RECEPTOR KINASE IN COMPLEX WITH A BISUBSTRATE INHIBITOR'''<br />


==Overview==
==Overview==
Protein kinase inhibitors have applications as anticancer therapeutic, agents and biological tools in cell signaling. Based on a phosphoryl, transfer mechanism involving a dissociative transition state, a potent and, selective bisubstrate inhibitor for the insulin receptor tyrosine kinase, was synthesized by linking ATPgammaS to a peptide substrate analog via a, two-carbon spacer. The compound was a high affinity competitive inhibitor, against both nucleotide and peptide substrates and showed a slow off-rate., A crystal structure of this inhibitor bound to the tyrosine kinase domain, of the insulin receptor confirmed the key design features inspired by a, dissociative transition state, and revealed that the linker takes part in, the octahedral coordination of an active site Mg2+. These studies suggest, a general strategy for the development of selective protein kinase, inhibitors.
Protein kinase inhibitors have applications as anticancer therapeutic agents and biological tools in cell signaling. Based on a phosphoryl transfer mechanism involving a dissociative transition state, a potent and selective bisubstrate inhibitor for the insulin receptor tyrosine kinase was synthesized by linking ATPgammaS to a peptide substrate analog via a two-carbon spacer. The compound was a high affinity competitive inhibitor against both nucleotide and peptide substrates and showed a slow off-rate. A crystal structure of this inhibitor bound to the tyrosine kinase domain of the insulin receptor confirmed the key design features inspired by a dissociative transition state, and revealed that the linker takes part in the octahedral coordination of an active site Mg2+. These studies suggest a general strategy for the development of selective protein kinase inhibitors.


==Disease==
==Disease==
Line 11: Line 10:


==About this Structure==
==About this Structure==
1GAG is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with MG and 112 as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Transferase Transferase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.10.1 and 2.7.10.2 2.7.10.1 and 2.7.10.2] Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1GAG OCA].  
1GAG is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with <scene name='pdbligand=MG:'>MG</scene> and <scene name='pdbligand=112:'>112</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Transferase Transferase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.10.1 and 2.7.10.2 2.7.10.1 and 2.7.10.2] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1GAG OCA].  


==Reference==
==Reference==
Line 18: Line 17:
[[Category: Single protein]]
[[Category: Single protein]]
[[Category: Transferase]]
[[Category: Transferase]]
[[Category: Ablooglu, A.J.]]
[[Category: Ablooglu, A J.]]
[[Category: Cole, P.A.]]
[[Category: Cole, P A.]]
[[Category: Hubbard, S.R.]]
[[Category: Hubbard, S R.]]
[[Category: Kohanski, R.A.]]
[[Category: Kohanski, R A.]]
[[Category: Parang, K.]]
[[Category: Parang, K.]]
[[Category: Till, J.H.]]
[[Category: Till, J H.]]
[[Category: 112]]
[[Category: 112]]
[[Category: MG]]
[[Category: MG]]
Line 29: Line 28:
[[Category: tyrosine kinase]]
[[Category: tyrosine kinase]]


''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 17:02:18 2007''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 12:48:00 2008''